Get your flu shot at Genoa this fall! Find a pharmacy location near you.
The latest news and insights from Genoa Healthcare.
For consumers living with opioid use disorder (OUD), medication-assisted treatment (MAT) has become the gold standard of treatment. In a new webinar, Genoa Healthcare Director of Operations Megan Garrity, PharmD,...
FDA Approves 14 New Medications The FDA has approved 14 new medication and treatment options for the behavioral health space to date in 2022. The new medication and treatment options...
Treating Schizophrenia Long-acting injectable (LAI) antipsychotic formulations are being considered more often in the treatment of schizophrenia to promote medication adherence. Genoa Healthcare recently hosted a webinar providing an update...
Behavioral Health Drug Updates This year the Federal Drug Administration’s Center for Drug Evaluation and Research (CDER) approved a number of new drug therapies to treat behavioral health conditions, including...
Behavioral Drug Approvals in 2020 The FDA’s Center for Drug Evaluation and Research approved 53 new drugs in 2020 alone, including several novel treatments for schizophrenia and other behavioral health...
A Rise in Drug Overdoses Deaths from drug overdoses, which have climbed steadily over the past 20 years, rose sharply during the COVID-19 pandemic. This “epidemic within the pandemic” underscored...
Medication-Assisted Treatment for PTSD Pharmacist Terri Taylor has worked behind the pharmacy counter for 32 years and has research experience at The University of Kansas School of Pharmacy. Over her...
By Stephanie Kornechuk, Pharm D Senior Vice President, Procurement & Network Management, Genoa Healthcare Drug Shortages Affecting Behavioral Health Therapies New drug approvals have created new treatment options for those...
This story was featured in the Boston Globe. Click here to read the article. Lifespan affiliate awarded $1.6M to help curb national opioid epidemic; will partner with pharmacy chain Genoa, treatment...